Readmissions to drug abuse treatment and HIV risk behavior

American Journal of Drug and Alcohol Abuse

Volumn 24, Issue 4, 1998, Pages 523-540

  McCusker, Jane ^a,b   Willis, Georgianna ^a   Vickers Lahti, Maureen ^a   Lewis, Benjamin ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b ST MARY S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; FEMALE; GENDER; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ILLNESS BEHAVIOR; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; RECURRENCE RISK; RISK FACTOR; SEXUAL BEHAVIOR;

EID: 0031770988     PISSN: 00952990     EISSN: None     Source Type: Journal    
DOI: 10.3109/00952999809019605     Document Type: Article

References (28)

1. Maddux, F., and Desmond, D. P., Relapse and recovery in substance abuse careers, in Relapse and Recovery in Drug Abuse (F. M. Tims and C. G. Leukefeld, Eds.), Research Monograph 72, National Institute on Drug Abuse, 1986.
2. Gerstein, D. R., and Lewin, L. S., Treating drug problems, N. Engl. J. Med. 323(12):844-848 (1990).
3. Simpson, D. D., and Savage, J. L., Drug abuse treatment readmissions and outcomes, Arch. Gen. Psychiatry 37:896-901 (1980).
4. Office of Technology Assessment, The Effectiveness of Drug Abuse Treatment: Implications for Controlling AIDS/HIV Infection, U.S. Government Printing Office, Washington, D.C., 1990.
5. Hubbard, R., Marsden, M., Cavanaugh, E., et al., Role of drug-abuse treatment in limiting the spread of AIDS, Rev. Infect. Dis. 10(2):377-384 (1988).
6. Sorensen, J. L., Preventing HIV transmission in drug treatment programs: What works? Adv. Alcohol Subst. Abuse 10:67-79 (1991).
7. McCusker, J., and Sorensen, J., HIV and therapeutic communities, in Therapeutic Community: Advances in Research and Application (F. Tims, G. DeLeon, and N. Jainchill, Eds.), Research Monograph 144, National Institute on Drug Abuse, 1994.
8. Calsyn, D. A., Saxon, A., Freeman, G., et al., Ineffectiveness of AIDS education and HIV antibody testing in reducing high-risk behaviors among injection drug users. Am. J. Public Health 82(4):573-575 (1992).
9. Baker, A., Heather, N., Wodak, A., et al., Evaluation of a cognitive-behavioural intervention for HIV prevention among injecting drug users, AIDS 7:247-256 (1993).
10. McCusker, J., Stoddard, A., Zapka, J., et al., AIDS education for drug abusers: Evaluation of short-term effectiveness, Am. J. Public Health 82:533-540 (1992).
11. McCusker, J., Stoddard, A., Zapka, J., et al., Behavioral outcomes of AIDS educational interventions for drug abusers in short-term drug treatment, Am. J. Public Health 89:1463-1466 (1993).
12. Centers for Disease Control, Coordinated community programs for HIV prevention among intravenous drug users, MMWR Morb. Mortal. Wkly. Rep. 38:369-374 (1989).
13. McCusker, J., Koblin, B., Lewis, B. F., et al., Demographic characteristics, risk behaviours, and HIV seroprevalence among intravenous drug users by site of contact: Results from a community-wide HIV surveillance project, Am. J. Public Health 80:1062-1067 (1990).
14. McCusker, J., Willis, G., McDonald, M., et al., Admissions of injection drug users to drug abuse treatment following HIV counseling and testing, Public Health Rep. 109(2):212-218 (1994).
15. Lewis, B., McCusker, J., Hindin, R., et al., Four residential drug treatment programs: Project IMPACT, in Innovative Strategies in the Treatment of Drug Abuse (J. Inciardi, F. Tims, and B. Fletcher, Eds.), Greenwood, Westport, Connecticut, 1993, pp. 45-60.
16. Morrison, C. S., McCusker, J., Stoddard, A. M., et al., The validity of behavioral data reported by injection drug users on a clinical risk assessment, Int. J. Addict. 30:898-899 (1995).
17. McCusker, J., Willis, G., McDonald, M., et al., Communitywide HIV counselling and testing in Central Massachusetts: Who is retested and does their behavior change? J. Community Health 21:11-22 (1996).
18. Delrala, J., Bigelow, C., McCusker, J., et al., Reliability of self-reported HIV risk behaviors in a residential drug treatment population, Am. J. Epidemiol. 143:725-732 (1996).
19. McCusker, J., Stoddard, A. M., and McCarthy, E., The validity of self-reported HIV-1 antibody test results, Am. J. Public Health 82:567-569 (1992).
20. SAS, SAS/SAT Guide for Personal Computers, Version 6.04, SAS Institute, Cary, North Carolina, 1990.
21. Peterson, K. A., Swindle, R. W., Phibbs, C. S., et al., Determinants of readmission following inpatient substance abuse treatment: A national study of VA programs, Med. Care 32(6):535-550 (1994).
22. Graeven, D., and Graeven, K., Treated and untreated addicts: Factors associated with participation in treatment and cessation of heroin use, J. Drug Issues 207-218 (Spring 1983).
23. Power, R., Hartnoll, R., and Daviaud, R., Drug injecting, AIDS, and risk behavior: Potential for change and intervention strategies, Br. J. Addict. 83:649-654 (1988).
24. McCusker, J., Bigelow, C., Stoddard, A., et al., HIV-1 antibody Status and changes in risk behavior among drug users, Ann. Epidemiol. 4(6):466-471 (1994).
25. McCusker, J., Bigelow, C., Frost, R., et al., The relationships of HIV status and HIV risky behavior with readiness for treatment, Drug Alcohol Depend. 109(2):212-218 (1994).
26. Hudgins, R., McCusker, J., and Stoddard, A., Cocaine use and risky injection and sexual behaviors, Drug Alcohol Depend. 37:7-14 (1995).
27. McCusker, J., Bigelow, C., Luippold, R., et al., Outcomes of inpatient drug detoxification: Retention, transfer to further treatment, and relapse, Am. J. Drug Alcohol Abuse 21:1-16 (1995).
28. McCusker, J., Stoddard, A., Zapka, J., et al., Use of condoms by heterosexually active drug abusers before and after AIDS education. Sex. Transm. Dis. 20:81-88 (1993).